433 related articles for article (PubMed ID: 23577497)
1. Clinical challenges and unmet needs in the management of complicated intra-abdominal infections.
Mazuski JE
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-49-69. PubMed ID: 23577497
[TBL] [Abstract][Full Text] [Related]
2. Role of moxifloxacin for the treatment of community-acquired [corrected] complicated intra-abdominal infections in Taiwan.
Lau YJ; Chen YH; Huang CT; Lee WS; Liu CY; Liu JW; Liu HD; Lee YJ; Chen CW; Ko WC; Hsueh PR
J Microbiol Immunol Infect; 2012 Feb; 45(1):1-6. PubMed ID: 22244019
[TBL] [Abstract][Full Text] [Related]
3. Therapy of 1,025 severely ill patients with complicated infections in a German multicenter study: safety profile and efficacy of tigecycline in different treatment modalities.
Bodmann KF; Heizmann WR; von Eiff C; Petrik C; Löschmann PA; Eckmann C
Chemotherapy; 2012; 58(4):282-94. PubMed ID: 23052187
[TBL] [Abstract][Full Text] [Related]
4. Inadequate Source Control and Inappropriate Antibiotics are Key Determinants of Mortality in Patients with Intra-Abdominal Sepsis and Associated Bacteremia.
Tellor B; Skrupky LP; Symons W; High E; Micek ST; Mazuski JE
Surg Infect (Larchmt); 2015 Dec; 16(6):785-93. PubMed ID: 26258265
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial de-escalation strategies in hospitalized patients with pneumonia, intra-abdominal infections, and bacteremia.
Kaye KS
J Hosp Med; 2012; 7 Suppl 1():S13-21. PubMed ID: 23737333
[TBL] [Abstract][Full Text] [Related]
6. Duration and cessation of antimicrobial treatment.
File TM
J Hosp Med; 2012; 7 Suppl 1():S22-33. PubMed ID: 23677632
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial de-escalation strategies in hospitalized patients with pneumonia, intra-abdominal infections, and bacteremia.
Kaye KS
J Hosp Med; 2012; 7 Suppl 1():S13-21. PubMed ID: 23677630
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies.
Eckmann C; Montravers P; Bassetti M; Bodmann KF; Heizmann WR; Sánchez García M; Guirao X; Capparella MR; Simoneau D; Dupont H
J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii25-35. PubMed ID: 23772043
[TBL] [Abstract][Full Text] [Related]
9. Duration of Antimicrobial Therapy in Treating Complicated Intra-Abdominal Infections: A Comprehensive Review.
Sartelli M; Catena F; Ansaloni L; Coccolini F; Di Saverio S; Griffiths EA
Surg Infect (Larchmt); 2016 Feb; 17(1):9-12. PubMed ID: 26468904
[TBL] [Abstract][Full Text] [Related]
10. Current strategies for the treatment of complicated intraabdominal infections.
Skrupky LP; Tellor BR; Mazuski JE
Expert Opin Pharmacother; 2013 Oct; 14(14):1933-47. PubMed ID: 23876130
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.
Goldstein EJ; Solomkin JS; Citron DM; Alder JD
Clin Infect Dis; 2011 Dec; 53(11):1074-80. PubMed ID: 21998288
[TBL] [Abstract][Full Text] [Related]
13. The empiric treatment of nosocomial intra-abdominal infections.
Dupont H
Int J Infect Dis; 2007 May; 11 Suppl 1():S1-6. PubMed ID: 17603948
[TBL] [Abstract][Full Text] [Related]
14. Postoperative bacterial/fungal infections: a challenging problem in critically ill patients after abdominal surgery.
Lichtenstern C; Schmidt J; Knaebel HP; Martin E; Büchler MW; Weigand MA
Dig Surg; 2007; 24(1):1-11. PubMed ID: 17259712
[TBL] [Abstract][Full Text] [Related]
15. Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections--are they applicable today?
Caínzos M
Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():9-18. PubMed ID: 19040462
[TBL] [Abstract][Full Text] [Related]
16. Clinical challenges and unmet needs in the management of complicated skin and skin structure, and soft tissue infections.
Turina M; Cheadle WG
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-23-36. PubMed ID: 23577495
[TBL] [Abstract][Full Text] [Related]
17. Patients with Complicated Intra-Abdominal Infection Presenting with Sepsis Do Not Require Longer Duration of Antimicrobial Therapy.
Rattan R; Allen CJ; Sawyer RG; Askari R; Banton KL; Claridge JA; Cocanour CS; Coimbra R; Cook CH; Cuschieri J; Dellinger EP; Duane TM; Evans HL; Lipsett PA; Mazuski JE; Miller PR; O'Neill PJ; Rotstein OD; Namias N
J Am Coll Surg; 2016 Apr; 222(4):440-6. PubMed ID: 26920994
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli.
Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
Scand J Infect Dis; 2011 Mar; 43(3):202-8. PubMed ID: 21142623
[TBL] [Abstract][Full Text] [Related]
19. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
Napolitano LM
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies.
Guirao X; Sánchez García M; Bassetti M; Bodmann KF; Dupont H; Montravers P; Heizmann WR; Capparella MR; Simoneau D; Eckmann C
J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii37-44. PubMed ID: 23772045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
